Serum osteoprotegerin is a major determinant of bone density development and prevalent vertebral fracture status following cardiac transplantation
- 1 January 2003
- journal article
- research article
- Published by Elsevier BV in Bone
- Vol. 32 (1), 96-106
- https://doi.org/10.1016/s8756-3282(02)00926-2
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- High prevalence of osteoporosis in cardiac transplant recipients and discordance between biochemical turnover markers and bone histomorphometryClinical Endocrinology, 1999
- Mechanisms of bone loss after cardiac transplantationBone, 1998
- Bone Loss and Turnover after Cardiac TransplantationJournal of Clinical Endocrinology & Metabolism, 1997
- Cyclosporine induces high bone turnover and may contribute to bone loss after heart transplantationEuropean Journal of Clinical Investigation, 1996
- Fracture after cardiac transplantation: a prospective longitudinal studyJournal of Clinical Endocrinology & Metabolism, 1996
- PREVENTION OF BONE LOSS IN CARDIAC TRANSPLANT RECIPIENTSTransplantation, 1996
- Timing and quantification of bone loss in cardiac transplant recipientsTransplant International, 1995
- Mechanisms of rapid bone loss following cardiac transplantationOsteoporosis International, 1994
- Osteoporosis and bone morbidity in cardiac transplant recipientsAmerican Journal Of Medicine, 1994
- Osteoporosis after cardiac transplantationAmerican Journal Of Medicine, 1993